LCTX
Lineage Cell Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Lineage Cell Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Lineage Cell Therapeutics, Inc.
1.01
−0.02 · −2.30%
post 1.01 0.00%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Broadwood CapitalBroadwood Capital | $64.9M | 42.52% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $17.3M | 11.31% | +241.21% | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $11.9M | 7.77% | +8.85% | |
| 4 | Defender CapitalDefender Capital | $8.6M | 5.66% | −1.94% | |
| 5 | Geode Capital ManagementGeodeindex-like | $6.9M | 4.55% | +110.04% | |
| 6 | Raffles AssociatesRaffles | $6.8M | 4.46% | −3.08% | |
| 7 | Fifth Third BancorpFifth Third Bancorp | $6.0M | 3.95% | 0.00% | |
| 8 | Millennium ManagementMillennium | $4.0M | 2.59% | −45.72% | |
| 9 | State StreetState Streetindex-like | $3.0M | 1.99% | +112.29% | |
| 10 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $2.2M | 1.43% | new | |
| 11 | Northern TrustNorthern Trustindex-like | $2.2M | 1.42% | +231.91% | |
| 12 | Morgan StanleyMorgan Stanley | $1.9M | 1.26% | −21.25% | |
| 13 | Renaissance TechnologiesRenaissance Technologies | $1.8M | 1.15% | −36.72% | |
| 14 | Marshall WaceMarshall Wace | $1.7M | 1.10% | −58.16% | |
| 15 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $1.7M | 1.09% | new | |
| 16 | UBS GroupUBS | $900,036 | 0.59% | −49.87% | |
| 17 | Red Crane Wealth ManagementRed Crane Wealth | $782,415 | 0.51% | 0.00% | |
| 18 | Charles Schwab Investment ManagementCharles Schwabindex-like | $756,440 | 0.50% | +344.44% | |
| 19 | BarclaysBarclays | $666,354 | 0.44% | +29.33% | |
| 20 | Citadel AdvisorsCitadel | $609,896 | 0.40% | +180.04% | |
| 21 | Squarepoint OpsSquarepoint Ops | $582,654 | 0.38% | +210.62% | |
| 22 | Goldman Sachs GroupGoldman Sachs | $567,578 | 0.37% | −62.95% | |
| 23 | Bank of AmericaBank of America | $555,928 | 0.36% | +1.20% | |
| 24 | Bank of New York MellonBank of New York Mellonindex-like | $513,094 | 0.34% | +1587.31% | |
| 25 | Putnam FL Investment ManagementPutnam FL | $398,976 | 0.26% | new |
129 managers report $152.7M of Lineage Cell Therapeutics on form 13F for the quarter ended Jun 30 '26. 7 of them hold 80% of it; Broadwood Capital is largest at 42.52%.
Expected move
No implied move.
No implied move.
No implied move.